Share:
Peer-Reviewed Publication
World J Urol2026;44(1)August 13, 2026Journal Article

Assessing the trifecta of enucleation using Magneto laser energy on different prostate volumes in real world practice, an EAU-endourology and AUSET collaboration.

Vineet Gauhar1,2, Daniele Castellani1,3, Bhaskar Somani4, Ioannis Kartalas Goumas5, Karl Tan6, Biligere Sarvajit2, Khi Yung Fong7, Steffi Kar-Kei Yuen1,8, Marek Zawadzki9, Giorgio Bozzini10, Thomas Herrmann1,11,12,13, Ee Jean Lim14
1Endourology Section of the European Association of Urology, Arnhem, The Netherlands.
2Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore.
3Department of Medicine and Surgery, LUM University, Casamassima, Bari, Italy.
4Department of Urology, University Hospital Southampton, NHS Trust, Southampton, UK.
5Division of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy.
6Department of Urology, Veterans Memorial Medical Center, Quezon City, Philippines.
7Urology Department, Singapore General Hospital, Outram Road, Singapore, Singapore.
8Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.
9Urology Unit, St. Anna Hospital, Piaseczno, Poland.
10Department of Urology, ASST Lariana, Sant'Anna Hospital, San Fermo della Battaglia, Como, Italy.
11Department of Urology, Kantonspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland.
12Division of Urology, Department of Surgical Sciences, Stellenbosch University, Stellenbosch, South Africa.
13Hannover Medical School, Hannover, Germany.
14Urology Department, Singapore General Hospital, Outram Road, Singapore, Singapore. eejeanlim@gmail.com.

Abstract

BACKGROUND: This study aimed to evaluate the real-world trifecta efficacy of the Magneto laser technology used in endoscopic enucleation of the prostate (EEP), defined by three criteria: absence of Clavien-Dindo grade II, III, or IV complications within the first 30 days postoperatively; maximum urinary flow rate (Qmax) > 15 ml/sec within 3 months; and the absence of stress urinary incontinence be…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.